A Mitogen-activated Protein Kinase Pathway Is Required for μ-Opioid Receptor Desensitization

The μ-opioid receptor mediates not only the beneficial painkilling effects of opiates like morphine but also the detrimental effects of chronic exposure such as tolerance and dependence. Different studies have linked tolerance to opioid receptor desensitization. Agonist activation of the μ-opioid...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 1998-05, Vol.273 (20), p.12402
Main Authors: Roberto D. Polakiewicz, Sandra M. Schieferl, Lydia F. Dorner, Vikram Kansra, Michael J. Comb
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The μ-opioid receptor mediates not only the beneficial painkilling effects of opiates like morphine but also the detrimental effects of chronic exposure such as tolerance and dependence. Different studies have linked tolerance to opioid receptor desensitization. Agonist activation of the μ-opioid receptor stimulates a mitogen-activated protein kinase (MAPK) activity, but the functional significance of this pathway remains unclear. We have focused on the MAPK signaling cascade to study μ-opioid receptor desensitization. We report that inhibition of the MAPK pathway blocks desensitization of μ-opioid receptor signaling as well as the loss of receptor density due to internalization. Our results suggest that a feedback signal emanating from the MAPK cascade is required for μ-opioid receptor desensitization.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.273.20.12402